CHIEF OPERATING OFFICER · Kiniksa Pharmaceuticals International, plc · Class A Ordinary Share
Side
SELL
Value
$1.40M
Shares
15.1K
Price
$92.81
Executed
Oct 30, 2026
Disclosed
Nov 3, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Oct 30 executedNov 3, 2026 disclosed
KNSA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Moat Ross filed this Form 4 reporting a open-market sale of KNSA on Oct 30, 2026. It became public on Nov 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
